Gold Nanoparticles in Cancer Theranostics
Qinyue Gao,Jingjing Zhang,Jie Gao,Zhengyang Zhang,Haitao Zhu,Dongqing Wang,Qinyue Gao,Jingjing Zhang,Jie Gao,Zhengyang Zhang,Haitao Zhu,Dongqing Wang
DOI: https://doi.org/10.3389/fbioe.2021.647905
IF: 5.7
2021-04-13
Frontiers in Bioengineering and Biotechnology
Abstract:Conventional cancer treatments, such as surgical resection, radiotherapy, and chemotherapy, have achieved significant progress in cancer therapy. Nevertheless, some limitations (such as toxic side effects) are still existing for conventional therapies, which motivate efforts toward developing novel theranostic avenues. Owning many merits such as easy surface modification, unique optical properties, and high biocompatibility, gold nanoparticles (AuNPs and GNPs) have been engineered to serve as targeted delivery vehicles, molecular probes, sensors, and so on. Their small size and surface characteristics enable them to extravasate and access the tumor microenvironment (TME), which is a promising solution to realize highly effective treatments. Moreover, stimuli-responsive properties (respond to hypoxia and acidic pH) of nanoparticles to TME enable GNPs’ unrivaled control for effective transport of therapeutic cargos. In this review article, we primarily introduce the basic properties of GNPs, further discuss the recent progress in gold nanoparticles for cancer theranostics, with an additional concern about TME stimuli-responsive studies.
multidisciplinary sciences